Search

This study aimed to investigate the possible neuroprotective effects of bitter melon (BM), chard, and parsley extracts on oxidative damage that may occur in the brain of rats with bile duct ligation (BDL)-induced biliary cirrhosis. It was observed that lipid peroxidation (LPO), sialic acid (SA), and nitric oxide (NO) levels increased; glutathione (GSH) levels, catalase (CAT) activity, and tissue factor (TF) activity decreased significantly in the BDL group. However, in groups with BDL given BM, chard, and parsley extracts LPO, SA, NO levels decreased; GSH levels and CAT activities increased significantly. No significant differences were observed between groups in total protein, glutathione-S-transferase, superoxide dismutase, and boron. Histological findings were supported by the biochemical results. BM, chard, and parsley extracts were effective in the regression of oxidant damage caused by cirrhosis in the brain tissues. PRACTICAL APPLICATIONS: Bitter melon (BM), chard, and parsley have antioxidant properties due to their bioactive compounds which are involved in scavenging free radicals, suppressing their production, and stimulating the production of endogenous antioxidant compounds. Since BM, chard, and parsley extracts were found to be effective in the regression of oxidant damage caused by cirrhosis in the brain tissues, these plant extracts may be an alternative in the development of different treatment approaches against brain damage in cirrhosis. At the same time, these species have been used as food by the people for many years. Therefore, they can be used safely as neuroprotective agents in treatment.

The aim of this study was to examine the effects of chard on valproic acid (VPA)-induced cardiac damage. Female Sprague-Dawley rats were grouped as control, chard given control (100 mg/kg/day, by gavage), VPA (500 mg/kg/day, intraperitoneally) and chard given VPA (100 mg/kg/day chard by gavage, 500 mg/kg/day VPA, intraperitoneally). The aqueous extracts of chard leaves were given 1 h prior to administration of VPA for 7 days. Malondialdehyde (MDA), total sialic acid (SA) levels and catalase (CAT) activity significantly increased in the VPA group compared with the control group (P

This study was aimed at investigating morphological and biochemical efficacies of antioxidants on indomethacin-induced small intestinal damage in rats. Group I: control animals (negative control) given only placebo, Group II: (positive control) are animals orally given combination of antioxidants [vitamin C (Vit C), vitamin E (Vit E), β-carotene and sodium selenite (Se)] daily for 3 days, Group III: Rats were given only indomethacin, Group IV: animals were given of antioxidants combination for 3 days, last dose was given 2 hr before the administration of indomethacin. Group V: Animals receiving ranitidine for 3 days (second positive control). Group VI: Animals received ranitidine for 3 days, last dose was given 2 hr before to indomethacin administration. Indomethacin caused degenerative morphological and biochemical changes, which were reversed on antioxidants administration. As a result, we propose that antioxidants combination would be therapeutically beneficial for treating indomethacin-induced lesions of small intestine. PRACTICAL APPLICATIONS: Indomethacin is a widely preferred nonsteroidal anti-inflammatory drug (NSAID) but its side effects on gastrointestinal system are well known. Indomethacin also causes production of reactive oxygen species. Antioxidants and selenium has protective effects. According to the results of this study, antioxidants and selenium can be used as a food supplement for preventing NSAID-induced side effects and toxicity.

Pistacia atlantica Desf. (Anacardiaceae), a tree that is widely distributed in the Marmara, Mediterranean and Central Anatolia regions of Turkey, has been utilized traditionally for culinary and medicinal purposes. In the present study, methanolic and ethyl acetate extracts were prepared from young leaves of P. atlantica Desf., which were collected during the spring, and their antioxidant, scavenging, chelating and anti-acetylcholinesterase activities were evaluated. Both of the extracts showed strong antioxidant activity compared to synthetic antioxidants such as butylated hydroxyanisole, butylated hydroxytoluene and α-tocopherol whereas they exhibited relatively lower level of anti-acetylcholinesterase activity. The acetylcholinesterase inhibitory effect of the ethylacetate extract was higher than the inhibitory effect of the methanolic extract. Therefore, the extracts of the young leaves of P. atlantica Desf. might be a potential antioxidant supplement for food and pharmaceutical products. It might also be used to stabilize the foods against oxidative deterioration. PRACTICAL APPLICATIONS Pistacia atlantica Desf. (Anacardiaceae) is a tree located in the Marmara, Mediterranean and Central Anatolia regions of Turkey. The genus Pistacia includes at least 11 species. The mastic obtained from Pistacia species has been used as urinary and respiratory antiseptic in Turkish folk medicine. During the spring, the young leaves of P. atlantica Desf. are used as a vegetable and commonly consumed as cooked food in the Mediterranean and East Anatolian parts of Turkey. Pistacia species have been reported to posses anti-inflammatory, antipyretic, antifungal, antimicrobial, antiviral, anti-insect, anti-atherogenic, hypoglycemic, anticancer and hepatoprotective activities. The aerial parts and/or resin of the plant has been also used in traditional medicine for the treatment of eczema, paralysis, diarrhea, throat infections, renal stones, jaundice, asthma and stomach ache, and also as an astringent and a pectoral stimulant. According to our results, the high antioxidant properties of the leaves of P. atlantica Desf. might be beneficial to the antioxidant protection system of the human body against oxidative damage.